| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8833908 | Journal of the American College of Surgeons | 2017 | 10 Pages |
Abstract
Our study suggests that trastuzumab therapy in conjunction with breast reconstructive operation is not associated with reconstructive complications, and breast reconstruction does not need to be delayed due to the administration of trastuzumab. Future studies are needed to evaluate the impact of pertuzumab on surgical outcomes.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Ronnie L. BS, Eugenia H. BS, Adam D. BS, Luke P. BS, Lily R. MD, Rachel A. MD, MPH, Kimberly L. MD, Scott T. MD, FACS,